2026 CDG Miniseries | The Future of Drug Repurposing | Dr. Ethan Perlstein | Episode NINE

2026 CDG Miniseries | Episode NINE From the 2026 CDG Scientific & Family Conference, Dr. Ethan Perlstein, Founder and CEO of Perlara, presents: "The Future of Drug Repurposing: Vision, Disruption, and What Must Change" Drug repurposing has emerged as one of the most promising strategies for accelerating therapeutic development in rare diseases. In this thought-provoking session, Dr. Perlstein shares his vision for the future of drug repurposing, examines barriers that continue to slow progress, and discusses what must change to create a more efficient path from scientific discovery to patient impact. Drawing on years of experience working alongside rare disease communities, Dr. Perlstein explores how patient organizations, researchers, industry, and emerging technologies can work together to disrupt traditional development models and accelerate treatment discovery. Topics include: drug repurposing, rare disease therapies, therapeutic development, innovation, biotechnology, patient-led research, translational science, precision medicine, AI-enabled discovery, and the future of rare disease treatment. The CDG CARE 2026 Education & Research Miniseries brings expert conference presentations directly to the global CDG community, featuring clinicians, researchers, and families sharing knowledge to advance education, research, and care for individuals living with CDG. 📺 Subscribe to the CDG CARE YouTube Channel for new weekly episodes from the 2026 CDG Scientific & Family Conference. Learn more about CDG CARE: https://cdgcare.org #CDG #DrugRepurposing #RareDisease #Innovation #Research